141 related articles for article (PubMed ID: 37300936)
21. Imaging of Radiation- and Medication-Related Osteonecrosis.
Mallya SM; Tetradis S
Radiol Clin North Am; 2018 Jan; 56(1):77-89. PubMed ID: 29157550
[TBL] [Abstract][Full Text] [Related]
22. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the cone beam computed tomography findings in medication-related osteonecrosis of the jaws related to denosumab versus bisphosphonates: an observational pilot study.
Pichardo SEC; Broek FWT; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Apr; 129(4):411-417. PubMed ID: 32001241
[TBL] [Abstract][Full Text] [Related]
24. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
[TBL] [Abstract][Full Text] [Related]
25. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
Muttanahally KS; Tadinada A
Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
[TBL] [Abstract][Full Text] [Related]
26. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
27. Bone-within-bone appearance: a red flag for biphosphonate-associated osteonecrosis of the jaw.
Fatterpekar GM; Emmrich JV; Eloy JA; Aggarwal A
J Comput Assist Tomogr; 2011; 35(5):553-6. PubMed ID: 21926848
[TBL] [Abstract][Full Text] [Related]
28. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
McGowan K; Ivanovski S; Acton C
Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
[TBL] [Abstract][Full Text] [Related]
29. Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.
Van Camp N; Verhelst PJ; Nicot R; Ferri J; Politis C
J Oral Maxillofac Surg; 2021 Sep; 79(9):1892-1901. PubMed ID: 34097863
[TBL] [Abstract][Full Text] [Related]
30. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
31. Osseous changes in patients with medication-related osteonecrosis of the jaws.
Gönen ZB; Yillmaz Asan C; Zararsiz G; Kiliç E; Alkan A
Dentomaxillofac Radiol; 2018 Jan; 47(1):20170172. PubMed ID: 28871814
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-Related Osteonecrosis of the Jaw Bone: Radiological Pattern and the Potential Role of CBCT in Early Diagnosis.
Olutayo J; Agbaje JO; Jacobs R; Verhaeghe V; Velde FV; Vinckier F
J Oral Maxillofac Res; 2010; 1(2):e3. PubMed ID: 24421968
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.
Miyashita H; Kameyama K; Morita M; Nakagawa T; Nakahara T
Dentomaxillofac Radiol; 2019 Dec; 48(8):20190208. PubMed ID: 31287720
[TBL] [Abstract][Full Text] [Related]
34. Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.
Zadik Y; Ganor Y; Rimon O; Bersudski E; Meirovitz A
Radiother Oncol; 2021 Mar; 156():275-280. PubMed ID: 33373641
[TBL] [Abstract][Full Text] [Related]
35. Cone beam computed tomography for diagnosis of bisphosphonate-related osteonecrosis of the jaw: evaluation of quantitative and qualitative image parameters.
Guggenberger R; Koral E; Zemann W; Jacobsen C; Andreisek G; Metzler P
Skeletal Radiol; 2014 Dec; 43(12):1669-78. PubMed ID: 24997160
[TBL] [Abstract][Full Text] [Related]
36. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.
Hong SO; Lee CY; Jung J; Kim DY; Walter C; Kwon YD
Clin Oral Investig; 2017 Jun; 21(5):1905-1911. PubMed ID: 27771829
[TBL] [Abstract][Full Text] [Related]
38. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
[TBL] [Abstract][Full Text] [Related]
39. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD; Fauvel F
Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
Clin Radiol; 2020 Jan; 75(1):46-50. PubMed ID: 31699430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
